A tissue-specific, activation-inducible, lentiviral vector regulated by human CD40L proximal promoter sequences.
about
Advances of gene therapy for primary immunodeficienciesGene transfer into hematopoietic stem cells as treatment for primary immunodeficiency diseases.Immunoglobulin class switch recombination deficiency type 1 or CD40 ligand deficiency: from bedside to bench and back again.Retroviral Transduction of T Cells and T Cell PrecursorsRegulated expression of murine CD40L by a lentiviral vector transcriptionally targeted through its endogenous promoter.Assembly PCR synthesis of optimally designed, compact, multi-responsive promoters suited to gene therapy application.
P2860
A tissue-specific, activation-inducible, lentiviral vector regulated by human CD40L proximal promoter sequences.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
A tissue-specific, activation- ...... L proximal promoter sequences.
@en
A tissue-specific, activation- ...... L proximal promoter sequences.
@nl
type
label
A tissue-specific, activation- ...... L proximal promoter sequences.
@en
A tissue-specific, activation- ...... L proximal promoter sequences.
@nl
prefLabel
A tissue-specific, activation- ...... L proximal promoter sequences.
@en
A tissue-specific, activation- ...... L proximal promoter sequences.
@nl
P2093
P2860
P356
P1433
P1476
A tissue-specific, activation- ...... L proximal promoter sequences.
@en
P2093
I J Molina
J D Unciti
P2860
P2888
P304
P356
10.1038/GT.2010.144
P577
2010-11-25T00:00:00Z
P5875
P6179
1049390003